LIQUAEMIN Drug Patent Profile
✉ Email this page to a colleague
When do Liquaemin patents expire, and when can generic versions of Liquaemin launch?
Liquaemin is a drug marketed by Aspen Global Inc and is included in one NDA.
The generic ingredient in LIQUAEMIN is heparin sodium. There are seventy-seven drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Liquaemin
A generic version of LIQUAEMIN was approved as heparin sodium by HOSPIRA on April 28th, 1983.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for LIQUAEMIN?
- What are the global sales for LIQUAEMIN?
- What is Average Wholesale Price for LIQUAEMIN?
Summary for LIQUAEMIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | LIQUAEMIN at DailyMed |
US Patents and Regulatory Information for LIQUAEMIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aspen Global Inc | LIQUAEMIN LOCK FLUSH | heparin sodium | INJECTABLE;INJECTION | 000552-007 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Aspen Global Inc | LIQUAEMIN SODIUM PRESERVATIVE FREE | heparin sodium | INJECTABLE;INJECTION | 000552-011 | Apr 11, 1986 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Aspen Global Inc | LIQUAEMIN SODIUM | heparin sodium | INJECTABLE;INJECTION | 000552-005 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Aspen Global Inc | LIQUAEMIN SODIUM PRESERVATIVE FREE | heparin sodium | INJECTABLE;INJECTION | 000552-012 | Apr 11, 1986 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
